Currently Recruiting

Dr Hemant Dhamne is Head of Process Development at the Kings College London Gene Therapy Vector Facility (GTVF). He is responsible for managing the team of Scientists to develop and improve the manufacturing process for viral vectors. Hemant is also Biosafety Supervisor and ensuring the safety compliance.

With a PhD in viral vector-engineering, and years of experience in cell and gene therapy, Hemant combines a viral vector biology and bioprocess engineering together to develop product and process for Advanced Therapy Medicinal Products.